KPF
CPXX

K2 Principal Fund’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

K2 Principal Fund’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-269,547
Closed -$8.13M – 365
2016
Q2 		$8.13M Buy
+269,547
New +$5.47M 1.07% 24

K2 Principal Fund's CPXX Position: Q3 2016 in Review

K2 Principal Fund sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 269,547 shares — an estimated $8.13M sold.

K2 Principal Fund first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $8.13M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • K2 Principal Fund reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • K2 Principal Fund sold 269,547 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $8.13M.
  • K2 Principal Fund first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • K2 Principal Fund's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $8.13M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on K2 Principal Fund's 13F filing for Q3 2016, filed 15 Nov 2016.